Top news of the week: 25.08.2020.
Biotechnology, Google, Health care, Initial public offering, Venture capital, Initial public offerings
Startups
This big data startup raised $12 million to speed up clinical trials for coronavirus research
https://t.co/xSy85GjjtN By @katiedjennings https://t.co/FCpUymFEyJ
OpenThis Big Data Startup Raised $12 Million To Speed Up Clinical Trials For Coronavirus Research
Cloud company Castor is powering 4,000 trials across 90 countries, including the World Health Organization’s Solidarity trial to discover Covid-19 treatments.
On Tuesday, 8/25 our Board Chairman Steve Tregay will lead panelists Kasper Roet of @QurAlisCo, Tim Clackson of @xiliotx, and @VikasGoyalVGVC of @PandionTx in a discussion about fundraising for biotech startups! https://t.co/UqN2AxJhDj
OpenJoin LabCentral on Tuesday, August 25 for a new episode of our series focused on innovation and biotech in the time of COVID-19.
Join LabCentral on Tuesday, August 25 for a new episode of our series focused on innovation and biotech in the time of COVID-19.
Johnson & Johnson invested in telhealth startup Thirty Madison –– signaling pharma companies will become more active investors in telehealth vendors https://t.co/eXO9UznuNh
OpenJohnson & Johnson participated in a $47 million funding round for telehealth startup Thirty Madison
Johnson & Johnson's $47 million investment in startup Thirty Madison signals pharma's swelling interest in the digital health space.
RT @Megan_Hernbroth: Do you know an awesome young investor that's leaving their mark in the healthcare world? I want to meet them!
We are officially accepting nominations for our ongoing "Rising Stars in VC" series. To apply, fill out this Google form by Friday, September 4: https://t.co/n9KroAUSyv
OpenBusiness Insider's Rising Stars of Health Tech investing
Hello! Our team at Business Insider is reviving our annual list of rising stars for health tech venture capital in line with our similar awards we have done for enterprise and fintech ...
MassBio is proud to announce that Abbie Celniker, Ph.D., Partner at @ThirdRockV, will receive the Henri A. Termeer Innovative Leadership Award during the #StateofPossible Conference on 8/26. To learn more about Abbie's influence & accomplishments, visit: https://t.co/R5oIWgr9F5 https://t.co/98qKfWBxsJ
OpenMassBio® to Honor Abbie Celniker with Henri A. Termeer Innovative Leadership Award
MassBio today announced that Abbie Celniker, Ph.D., Partner at Third Rock Ventures, will receive the Henri A. Termeer Innovative Leadership Award during its 2020 State of Possible ...
RT @Breakingviews: China Literature leaped 86% in its 2017 debut, but is now underwater, alongside similarly oversubscribed peers. Low interest rates have Hong Kong's retail investors back at playing IPOs, so another round of unsustainable pops is underway, says @AlecMac11: https://t.co/7lc3haabaK. https://t.co/KXBUm8CQjl
OpenRead in
The fan-fiction startup leaped 86% on its first trading day in 2017, but is now underwater, alongside peers that enjoyed similarly oversubscribed floats. Low interest rates have the city’s ...
.@harmonybio and InhibRx Raise Combined $247M in Public Market Debuts
- by @sarahdc
https://t.co/F8L1A34n0E
$INBX $HRMY
OpenHarmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts
Two biotechs this week topped the $100 million mark in their respective initial public offerings, both of which were able to offer more shares than
Genentech & Pfizer veteran Mike Varney is joining San Diego-based Erasca's leadership team as Chairman of Research & Development. Mike recently retired from Genentech after 15 yrs, was EVP R&D. Erasca CEO is @JLimMD, COO is Gary Yeung. https://t.co/hXWrw2pZbY Congrats
OpenErasca Recruits Michael Varney, Ph.D., as Chairman of Research & Development and Scientific Advisory Board Member
Erasca, a company whose mission is to erase cancer, today announced that Michael Varney, Ph.D., has joined the organization’s Scientific Advisory Boar